TCL Archive Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint May 31, 2013
TCL Archive BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile November 23, 1997
TCL Archive A Special Report: Language With A Purpose–von Eschenbach’s Four Years at NCI. May 19, 2006